RZLT: Rezolute Inc - (NV)

RZLT新闻

• 20:07 Rezolute完成Ersodetug用于肿瘤性高胰岛素血症（HI）的开放标签3期研究入组；顶线数据预计于2026年12月中旬公布
• 20:07 Rezolute Completes Enrollment In Open-Label Phase 3 Study Of Ersodetug In Tumor HI; Topline Data Expected In Mid-December 2026
• 12:39 This NetApp Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
• 20:01 Lake Street维持对Rezolute的买入评级，将目标价上调至12美元
• 20:01 Lake Street Maintains Buy on Rezolute, Raises Price Target to $12
• 12:58 Citizens Maintains Market Outperform on Rezolute, Raises Price Target to $15
• 12:07 这位博伊德博彩分析师转为看涨；以下是周二的五大升级推荐
• 12:07 This Boyd Gaming Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
• 10:42 Cantor Fitzgerald Upgrades Rezolute to Overweight
• 15:53 FDA Recommends Meeting for Rezolute Drug for Rare Blood Sugar Disorder Despite Missed Endpoints
• 11:09 Rezolute Gets FDA Recommendation For Pre-BLA Meeting Ahead Of Ersodetug BLA Submission For Congenital Hyperinsulinism Treatment.
• 16:00 Lake Street 对 Rezolute 给予买入评级并开始覆盖，宣布目标价为 9 美元
• 16:00 Lake Street Initiates Coverage On Rezolute with Buy Rating, Announces Price Target of $9
• 14:37 这位 Staar Surgical 分析师转为看涨；以下是周二的 5 大上调评级
• 14:37 This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
• 12:32 Craig-Hallum Upgrades Rezolute to Buy, Raises Price Target to $7
• 12:32 Craig-Hallum将Rezolute评级上调至“买入”，并将目标价上调至7美元
• 10:22 5 Stock Picks Last Week From Wall Street's Most Accurate Analysts
• 16:13 HC Wainwright & Co. Maintains Buy on Rezolute, Raises Price Target to $10
• 20:07 Rezolute Q4 EPS $(0.20) Misses $(0.15) Estimate
• 20:07 瑞祖利特第四季度每股收益为$(0.20)，低于预期的$(0.15)
• 17:33 Rezolute: Initiating At Sell Despite Attempts To Rescue Ersodetug Following sunRIZE Upset